Using some heartburn drugs may increase your risk of kidney problems

Using Some Heartburn Drugs May Increase Your Risk of Kidney Problems
Using Some Heartburn Drugs May Increase Your Risk of Kidney Problems

Taking a very common group of medications used to treat heartburn, ulcers and acid reflux could dramatically increase your risk of kidney disease and kidney failure, this according to new research out Thursday.

These drugs are called proton pump inhibitors, or PPIs, and you might even have one or two in your medicine cabinet right now.

SEE ALSO: Czechs pick 'Czechia' as one-word name after decades of hesitation

They're sold under the names Prilosec, Nexium and Prevacid, to name a few. And this new study claims those who take them are more likely than people on other heartburn medications to develop chronic kidney disease or kidney failure over a five-year period.

Related: See images of natural heartburn remedies

To come to this conclusion, researchers analyzed data from the Department of Veterans Affairs national databases.

They identified over 170,000 new users of PPIs and compared them to over 20,000 new users of histamine H2 receptor blockers, another class of drugs used to suppress stomach acid.

And after five years of follow-up, the researchers found the PPI users had a 28 percent increased risk of developing chronic kidney disease and a 96 percent increased risk of developing kidney failure, compared to those taking the alternative drugs.

Now, prolonged use of PPIs has been linked to several serious health problems in the past, including nutrient deficiencies, bone-density loss, slight increase in heart attack risk and even dementia.

But neither past studies or this most recent research definitively prove that PPIs are the culprits behind these issues. One of the researchers told HealthDay, "I cannot say for certain that this is cause-and-effect."

Still, to be safe, doctors warn people should only use PPIs when they're medically necessary and for the shortest amount of time possible.

As the study notes, about 15 million Americans were prescribed PPIs in 2013, though the number is likely higher because many are available over the counter.

See the biggest healthcare issues of the 2016 election: